|
ZNF256 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.45279998931392E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.31990000543192E-08 |
| Normal-vs-Stage2 |
6.96259999988236E-07 |
| Normal-vs-Stage3 |
1.95560012627993E-10 |
| Normal-vs-Stage4 |
8.01809996175962E-09 |
| Stage1-vs-Stage2 |
9.311400E-01 |
| Stage1-vs-Stage3 |
2.024200E-01 |
| Stage1-vs-Stage4 |
2.005200E-01 |
| Stage2-vs-Stage3 |
4.465200E-01 |
| Stage2-vs-Stage4 |
3.384600E-01 |
| Stage3-vs-Stage4 |
8.057200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.33959995610667E-09 |
| Normal-vs-AfricanAmerican |
1.898100E-03 |
| Normal-vs-Asian |
1.85502999999754E-05 |
| Caucasian-vs-AfricanAmerican |
3.132400E-01 |
| Caucasian-vs-Asian |
2.127800E-01 |
| AfricanAmerican-vs-Asian |
9.343600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.60720000033743E-07 |
| Normal-vs-Female |
2.37590003226984E-09 |
| Male-vs-Female |
1.178030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.10139999845538E-08 |
| Normal-vs-Age(41-60Yrs) |
3.02260438900248E-11 |
| Normal-vs-Age(61-80Yrs) |
1.94939997477661E-09 |
| Normal-vs-Age(81-100Yrs) |
9.162100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.221600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.060000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.885200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.531400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.524800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.550200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.174100E-02 |
| Classical-VS-Follicular |
1.174560E-01 |
| Classical-VS-Other |
8.992600E-01 |
| Classical-VS-Normal |
2.41990000038328E-07 |
| Tall-VS-Follicular |
5.095600E-01 |
| Tall-VS-Other |
4.567800E-01 |
| Tall-VS-Normal |
4.33539999455945E-08 |
| Follicular-VS-Other |
7.218000E-01 |
| Follicular-VS-Normal |
2.70540001512387E-09 |
| Other-VS-Normal |
2.976400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.02435854138139E-12 |
| Normal-vs-N1 |
2.6418000009798E-08 |
| N0-vs-N1 |
5.067200E-01 |
|
|
